Pancreatic Cancer Research

ResearcherUniversity of Florida HealthActive in the last 2 years

Song Han

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6542-335X; OpenAlex author ID A5037543325. Sources: OpenAlex.

Their work

Papers
18 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
29
Papers, trials and grants by year

2015: 1 paper · 2016: 1 paper · 2017: 1 paper · 2018: 1 paper · 2019: 1 paper · 2020: 3 papers · 2021: none · 2022: 2 papers · 2023: 2 papers · 2024: 4 papers · 2025: 1 paper · 2026: 1 paper

Papers 18

  1. The Rising Burden of Premature Mortality Due to Pancreatic Cancer in the United States. Co-author DOI 10.1097/mpa.0000000000002653↗
  2. A novel regimen for pancreatic ductal adenocarcinoma targeting MEK, BCL-xL, and EGFR. Co-author DOI 10.1016/j.neo.2024.101070↗
  3. Heterogeneity of weight loss and transcriptomic signatures in pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/jcsm.13390↗
  4. Variability of quality-of-life measurements and reporting in randomised controlled trials of pancreatic cancer: a systematic review. Co-author DOI 10.1136/bmjopen-2023-083696↗
  5. Fibroblasts in the Aged Pancreas Drive Pancreatic Cancer Progression. Co-author DOI 10.1158/0008-5472.can-24-0086↗
  6. Infiltration of CD3+ and CD8+ lymphocytes in association with inflammation and survival in pancreatic cancer. Co-author DOI 10.1371/journal.pone.0297325↗
  7. A peek at the other side of the coin: Tumor-suppressor role of microRNAs expressed by pancreatic cancer-associated fibroblasts. Last author DOI 10.1002/ctm2.1357↗
  8. A protein-based machine learning approach to the identification of inflammatory subtypes in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.pan.2023.06.007↗
  9. The interleukin-1 axis and the tumor immune microenvironment in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.neo.2022.100789↗
  10. Single-cell profiling of microenvironment components by spatial localization in pancreatic ductal adenocarcinoma. Co-author DOI 10.7150/thno.73222↗
  11. From tumor microenvironment communicants to biomarker discovery: Selectively packaged extracellular vesicular cargoes in pancreatic cancer. Co-author DOI 10.1016/j.cytogfr.2020.01.001↗
  12. Protein Signatures and Tissue Diagnosis of Pancreatic Cancer. Co-author DOI 10.1016/j.jamcollsurg.2019.10.002↗
  13. Nicotine Induces IL-8 Secretion from Pancreatic Cancer Stroma and Worsens Cancer-Induced Cachexia. Co-author DOI 10.3390/cancers12020329↗
  14. The Proteome of Pancreatic Cancer-Derived Exosomes Reveals Signatures Rich in Key Signaling Pathways. Co-author DOI 10.1002/pmic.201800394↗
  15. Stroma-derived extracellular vesicles deliver tumor-suppressive miRNAs to pancreatic cancer cells. Co-author DOI 10.18632/oncotarget.23532↗
  16. Human Pancreatic Cancer Cells Induce a MyD88-Dependent Stromal Response to Promote a Tumor-Tolerant Immune Microenvironment. Co-author DOI 10.1158/0008-5472.can-16-1765↗
  17. Nicotine Reduces Survival via Augmentation of Paracrine HGF-MET Signaling in the Pancreatic Cancer Microenvironment. Co-author DOI 10.1158/1078-0432.ccr-15-1256↗
  18. Downstream mediators of the intratumoral interferon response suppress antitumor immunity, induce gemcitabine resistance and associate with poor survival in hum… Co-author DOI 10.1007/s00262-015-1760-y↗

Closest collaborators

The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Steven J. Hughes · 18 shared papers, 2015–2026 · strength 2.80
  2. Gerik W. Tushoski-Alemán · 8 shared papers, 2022–2026 · strength 1.72
  3. Kelly M. Herremans · 7 shared papers, 2022–2024 · strength 1.34
  4. Patrick W. Underwood · 7 shared papers, 2019–2024 · strength 1.05
  5. Jose Gilberto Trevino · 8 shared papers, 2015–2025 · strength 1.01
  6. Andrea N. Riner · 5 shared papers, 2022–2024 · strength 0.90
  7. Thomas J. George · 6 shared papers, 2015–2025 · strength 0.67
  8. Christopher E Forsmark · 4 shared papers, 2018–2023 · strength 0.58
  9. Daniel Delitto · 6 shared papers, 2015–2024 · strength 0.52
  10. Michael H. Gerber · 5 shared papers, 2017–2022 · strength 0.48
  11. Jordan A. McKean · 1 shared paper, 2026 · strength 0.33
  12. Sarah M. Judge · 2 shared papers, 2020–2024 · strength 0.29
  13. Andrew R. Judge · 2 shared papers, 2020–2024 · strength 0.29
  14. Ryan Michael Thomas · 4 shared papers, 2015–2020 · strength 0.25
  15. Guangrong Zheng · 1 shared paper, 2025 · strength 0.24
  16. Daohong Zhou · 1 shared paper, 2025 · strength 0.24
  17. Vignesh Vudatha · 1 shared paper, 2024 · strength 0.19
  18. Ibrahim Nassour · 1 shared paper, 2023 · strength 0.18
  19. Ashani T. Weeraratna · 1 shared paper, 2024 · strength 0.17
  20. Samantha R. Guinn · 1 shared paper, 2024 · strength 0.17
  21. Daniel J. Zabransky · 1 shared paper, 2024 · strength 0.17
  22. Elizabeth M. Jaffee · 1 shared paper, 2024 · strength 0.17
  23. Jacquelyn W. Zimmerman · 1 shared paper, 2024 · strength 0.17
  24. K.E. Behrns · 3 shared papers, 2015–2017 · strength 0.15
  25. Shannon Margaret Wallet · 3 shared papers, 2015–2017 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.